Carl Icahn
Carl Icahn's Portfolio
| Ticker | # of Shares | Price | Value | |
|---|---|---|---|---|
| BIIB | 17,511,304 | $59.63 | $1,044,199,058 | |
| APC | 14,401,628 | $69.99 | $1,007,969,944 | |
| MOT | 137,741,443 | $7.18 | $988,983,561 | |
| YHOO | 55,039,056 | $16.44 | $904,842,081 | |
| IMCL | 11,669,544 | $69.99 | $816,751,385 | |
| LEA | 9,595,954 | $77.74 | $745,989,464 | |
| TWX | 12,933,159 | $31.24 | $404,031,888 | |
| TWC | 4,711,128 | $48.76 | $229,714,602 | |
| AMLN | 6,787,649 | $22.49 | $152,654,227 | |
| WMB | 3,918,959 | $22.53 | $88,294,147 | |
| View Additional Portfolio Information » | ||||
Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.
Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.
Icahn has successfully pushed for changes at Time Warner (NYSE: TWX) and Temple-Inland (NYSE: TIN), among others. Icahn won board seats at Motorola (NYSE: MOT) after first failing.
In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.
In early, 2008 Icahn activist target BEA Systems (Nasdaq: BEAS) was sold to Oracle (Nasdaq: ORCL). Icahn held a 13% stake in BEA.
Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.
In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.
